Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Health Outcomes Associates Ltd,Abiraterone,"Prostate cancer, same indications as for originator",Abiraterone (Yonsa),Only if cost neutral or cost saving,Community,
